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1.0  INTRODUCTION 
 
Emerging economies are increasing their importance 
in the global economic environment. In a recent 
articles, (Kearney, 2004) indicated the increasing 
importance of emerging economies such as Brazil, 
China, India, Mexico and Malaysia in the 
international economic environment. Such 
economies are expected to be home to a number of 
the world’s 500 largest enterprises in the next 20 
years. Even more striking is their suggestion that 
during this period, the economic centre of gravity of 
the world will shift towards countries that are 
currently classifies as developing countries. The 
trend is expected to gain momentum in coming years 
due to the fast relative growth of the economy of the 
developing versus developed countries, and the 
strategies of firms trying to secure first-mover 
advantages in emerging markets benefiting from 
economies of scale and locational advantages. 
 
These developments are not limited to low-and 
medium-technology initiatives as is frequently 
assumed in the literature on international business, 
but include a number of areas of high-technology. 
Emerging economies, in particular in Asia and in 
countries in transition, are expected to show strong 
technology-driven growth (Simos, 2000). In a survey 
sponsored by A.T. Kearney, more than 50 percent of 
200 senior multinational executives indicated 
technology and telecommunications sectors fuelling 
Asia’s growth over the next four years (cited in A.T. 
Kearney, 2004). Regional groupings of high 
technology enterprises are expected to attract a large 
number of these investors in emerging economies, as 
is the case of Malaysian Government Linked 
Companies in Malaysia (Far Eastern Economic 
Review, 2004; Ang, 2008). 
 
Biotechnology is one of the areas about which policy 
makers in these large emerging economies are 
particularly enthusiastic (Abdullah Badawi, 2004; 
Australian Government, 2005). Modern 
biotechnology, normally associated with genetic 
engineering, emerges at the end of this century as 
promoting an unparalleled technological revolution 
(OTA, 1984; EU White Paper, 1994). Although well 
advanced in developed countries, this 
biotechnological revolution has only started to reach 
emerging economies. International strategic 
alliances (ISA) may be one way to integrate 
emerging economies in its development. The use of 
various forms of co-operation between firms of 
emerging economies and firms of developed 
countries, including the ISA, can accelerate the 
process of transfer and adaptation of advances 
already reached in developed countries, as well as 
the development of new products and processes 
(Mytelka, 1999). It is particularly important when 
considering that biotechnology could solve 
humanity’s major problems clearly concentrated in 
developing countries (Hautea & Escaler, 2004; Ernst 
& Young, 2002; Quah & Arujanan, 2005). 
 
Malaysia can be seen as representative of other large 
emerging economies (China, Mexico, India and 
Poland) relative to high technology, or 
biotechnology in particular. Because its legislation 
was only modified to allow patenting of genetic 
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engineered microorganisms in 2005, Malaysia does 
not have a significant number of alliances in modern 
biotechnology (Abdullah Badawi, 2004; BIOTEK, 
2002). There has been a substantial increase in the 
inflow of foreign investments in this area since 
2005, particularly from large companies such as 
Monsanto, Hoechst-Schering, Dow Chemical and 
Du Pont (Adib, 2004; Chee and Kian, 2007; Karimi 
et al. 2009). Small-and medium–sized enterprises 
are also expected to benefit from these changes. The 
recognition of pharmaceutical patents (including 
biotechnological products) in Malaysia is expected 
to act as an incentive for the internal development of 
this technology or its adaptation to the local market 
(UNCTAD, 2008). The importance of this study 
derives also from the fact that there is a dearth of 
work in English about Malaysian business, and very 
few international strategic alliances in Malaysia in 
the area of biotechnology. 
 
2.0  THE BIOTECHNOLOGY SECTOR IN 
MALAYSIA 
 
Intermediary¹ biotechnology in Malaysia is well 
advanced in universities, private and governmental 
research centres. In modern biotechnology, however, 
the Malaysian picture is modest (Firdaus et al. 2003; 
Latifah et al. 2006). Malaysia has not been strongly 
participating in technological development in this 
field (Ford and Ryan, 2004). Nonetheless, some 
genetically modified products are expected to reach 
the market very soon as Malaysia and other Asian 
countries adjust to changes in patent regulation that 
affect the biotechnology sector (Cunningham, 1999). 
 
As one of the world’s largest producer of palm oil 
and rubber (Chemical Week, 1999; Chemical Week, 
2000), Malaysia has an enormous potential market 
for agricultural biotechnology products. 
Biotechnology has been identified as one of the five 
strategic technologies expected to accelerate 
Malaysia’s transformation into a highly 
industrialized nation by 2020. The Malaysian 
government strongly believes that biotechnology 
will propel the country into the new frontier of 
economic growth and attract foreign investment 
amounting to US$10 billion over the next 10 years 
(Hautea and Escaler, 2004; Abu et al. 2005). 
 
Malaysia aspires to be a biotechnology hub and this 
is clearly spelled out in the National Biotechnology 
Policy that was launched on the 28th. April 2005 
(MABIC, 2008). It is estimated that by 2020, this 
sector would create 280,000 jobs and contribute five 
per cent to the country’s Gross Domestic Product. 
Total investment under the National Biotechnology 
Policy is expected to be around US$7.9 billion. The 
policy which is expected to give impetus to the 
biotechnology sector in Malaysia addresses vital 
aspects of biotechnology development such as the 
priority areas, legal, safety, financial and other 
issues. The policy spells out nine thrusts, which 
include transforming and enhancing the value 
creation of the agricultural sector through 
biotechnology. The other area of priority is 
healthcare and industrial biotechnology. A total of 
US$800 million has been allocated for 
biotechnology in the Ninth Malaysia Plan. Out of 
this, an initial US$100 million has been allocated to 
Malaysian Biotechnology Corporation (Biotech 
Corp) to initiate commercialization, technology 
acquisition, entrepreneur development and for the 
development of intellectual property framework 
(MABIC, 2008). 
 
Presently, there are some biotechnology related 
industries in Malaysia, but most are using what can 
be classified as conventional biotechnology 
processes. Since Malaysia is largely an agricultural 
based country, it is not surprising that agricultural 
and food biotechnology received greater emphasis 
(Hassan, 2006). New developments in industrial 
biotechnology in Malaysia encompass activities such 
as optimization and enhancement of new treatment 
systems through bio-augmentation or genetic 
engineering. There are also a number of companies 
with special focus in bioinformatics (The Biotech 
Review 2006-2007). 
 
3.0 INTERNATIONAL STRATEGIC 
ALLIANCES 
 
By examining the gap in technology between 
developed and emerging economies, and consequent 
problems of the expansion of technological 
knowledge, there is a possible answer: co-operation 
among firms, in general, and, especially 
international strategic alliances and joint ventures. 
Alliances are suggested by Lorange and Roos (1993, 
p.9) as the most promising business strategy of the 
future. Dunning (1997) also acknowledges the 
increasing importance of international co-operations, 
in the form of joint ventures. Co-operation 
opportunities between small and large established 
firms can be found, according to Inkpen et al. 
(2004), especially in emerging industries. Kogut et 
al. (2002) also point out that these practices are 
frequently found in international business strategies 
of smaller companies. Such co-operative agreements 
may be used to enter emerging economies’ markets 
as well as to transfer technological knowledge. In 
their research, Kaplan and Hurd (2002) support this 
view, emphasizing that multinational executives, 
local executives, as well as host country government 
officials agree that in most cases, a joint venture 
associating a multinational firm and a private local 
firm, is the best arrangement to establish foreign 
direct investment for both the multinational and the 
host country (Najib, 2006; Doz and Hamel, 1998). 
 
The success rate of international strategic alliances 
in general is less than 40 per cent and could be as 
 
349 
low as 20 percent (Reuer and Zollo, 2000). In the 
specific area of this study, biotechnology alliances, 
success rates are estimated to be slightly higher. The 
importance of improving success rates of 
international strategic alliances cannot be 
underestimated as Parkhe (2003) points out, the need 
‘to improve the hit rate of strategic initiatives’ is a 
major challenge for corporations. Although post-
formation activities have been emphasized recently 
(Kuglin, 2002), pre-formation activities could have 
as much impact on alliance success. Our study 
emphasizes the latter point, indicating the 
importance of pre-alliance mechanisms that would 
increase the chances of choosing the right partner. In 
this context, Buckley and Casson (1998, pp.39-40) 
state that, co-operation success relates to 
characteristics of the management of the venture 
itself. It is assumed in this paper, that those 
characteristics will be associated with certain 
characteristics of the partners’ firms prior to the start 
of the alliance. In particular, co-operation success is 
expected to be linked to the views of executives of 
the partners’ firms regarding prospective 
contributions to the joint venture.  
 
4.0  PARTNERS’ POTENTIAL 
CONTRIBUTIONS 
 
Literature on international strategic alliance 
performance is abound (Beamish 1994). A few 
publications list potential contributions of partners of 
joint ventures or alliances: Stopford and Wells 
(1972), Beamish (1994); and more recently: 
Geringer (1991), Glaister and Buckley (1997), Dong 
et al. (1997), Parkhe (2003), Pan (2004), and 
Prahalad & Ramaswamy (2004).  
 
A list of the 18 most relevant contributions from 
local economy partners was compiled based mainly 
on the three initial papers. Three other papers 
published in Malaysia supplemented the information 
(although did not suggest lists of contributions); Sim 
(2006), Jomo and Shyamala (2001) and Sulaiman et 
al. (1999). Contributions are commented on below: 
 
 Capital: This item may be a contribution from 
one or all partner firms of the joint venture. It is 
understood as capital originating in either 
partner’s established business. 
 Access to raw materials: This can also be a 
contribution from any partner firm. It indicates 
the capability of the firm in overcoming 
problems in obtaining raw materials for 
production. These difficulties could be caused by 
factors such as governmental restrictions, 
geographic distances, tariffs, previous 
agreements with suppliers, distribution systems, 
etc. 
 General knowledge of the economy, politics, and 
customs: Given the appropriate qualification, this 
may be a contribution either from the local 
partner or from the foreign partner. Hence, when 
focusing on the local partner, ‘knowledge’ refers 
to the local economy, politics, and customs. As 
pointed out by Hitt et al. (2004) in their study of 
the institutional effects on strategic alliance 
partner selection process, it is an important 
contribution by the local partner. It could, 
however, be a contribution from the foreign 
partner, in which case ‘knowledge’ refers to the 
country where the foreign firm is based. It could 
prove valuable to the local partner if the joint 
venture plans to export. 
 Knowledge of local financing: This applies to the 
local partner. It concerns raising capital from 
third parties in the local market. It differs from 
the item ‘capital’. The latter implies the use of 
the firm’s own capital. Established firms would 
usually be expected to make this type of 
contribution to the venture. The former ‘having 
knowledge of local financing’, could be expected 
from a firm on good terms with banks, or 
development agencies. 
 Links to important personalities on the local 
scene: This could be expected from the local 
partner. It includes not only personalities from 
government but also those connected to research 
centre and universities. 
  Avoid political interventions: This is another 
contribution usually expected from the local 
partner. The foreign partner would have the risk 
of political intervention (e.g expropriation) 
reduced. Other intervention, such as price 
controls, or the establishment of governmental 
firms on the sector, would also present a lesser 
risk. 
 Political advantages: This can be used in relation 
to both local and foreign partners. The local 
partner could help as a ‘links to important 
personalities’. With regard to the foreign partner 
this contribution is understood as permission 
from foreign governments for the use of certain 
technologies, special tariffs, etc. 
 To meet governmental (legal) requirements for 
local ownership: The local partner can help here. 
It concerns regulations or policies of the host 
country such as import substitution, or the 
commercialization of certain products. In the 
case of Malaysia, Lee (2004) and Mytelka (1999) 
point out that it is easier to receive permission to 
commercialize or produce pharmaceuticals 
products when the multinational (foreign firm) 
has an association with a local firm. 
Governmental requirements concerning 
biotechnological products are included here 
(Jusoh, 2006). 
 Faster entry into the local market, considering 
the existing alternatives to the foreign partner; It 
is an important contribution from the local 
partner, and has been mentioned by other authors 
(Stopford and Wells, 1972; Beamish 1994) more 
broadly. By comparison other existing entry 
modes in a foreign market (exporting, licensing, 
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and wholly owned subsidiary) the importance of 
this can be seen. 
 Better access to the local market for goods 
produced by the joint venture than would have 
been possible with a wholly owned subsidiary; It 
is a subset of the previous item. It makes the 
comparison between the joint venture and the 
establishment of a subsidiary more explicit. 
Local partner contributions such as channels of 
distribution and administrative infrastructure are 
also included here. 
 Better access to the local market for goods 
produced abroad by the foreign partner: This 
item is definitely a potential advantage for the 
foreign partner. Its importance will depend on 
factors such as established channels of 
distribution and business infrastructure on the 
part of the local partner. 
 Better export opportunities for goods produced 
by the joint venture: This could be seen as 
possible contribution from either partner. The 
firms can also be seen as ‘spring boards’ to 
regional markets (e.g. ASEAN or APEC). The 
local partner can also be essential for raising 
export incentives from the host government. 
 Managing Director: On the one hand, this can be 
seen as a potential contribution of the local 
partner. It is considered that the joint venture 
would benefit with an experienced executive 
used to local practices (Susskind ,2005; Beamish 
1994). On the other hand, a foreign executive 
could contribute by bringing in up-to-date 
managerial practices to the venture. 
 Marketing managers: This is similar to the 
previous one but concentrating on the marketing 
position. Knowledge of cultural aspects could be 
essential for the development of a marketing 
strategy. In this case the choice of a local 
marketing manager would be more sensible. 
 Managers or experts in production, R & D or 
other technical area: This is usually seen as a 
contribution of the foreign partner because it is 
related to technology. It was pointed out by 
Curall and Inkpen (2003) as an important 
contribution of the local partner. Particularly 
when the venture involves technology transfer or 
product adaptation it seems reasonable that a 
qualified team on the local side would facilitate 
the process. 
 Cheap labour: This can be seen as a contribution 
from the host country. Holtbrugge (2004) points 
out, that local partners of a joint venture would 
be able to provide inexpensive labour more 
easily than a MNE operating with its own 
subsidiary. 
 Technology: Surprisingly, this contribution was 
ignored by Raved and Renford and also by 
Stopford and Wells. In contrast, Beamish (1994) 
and also Inkpen and Curall (2004), present it as 
one of the most important contributions of the 
foreign partner. The former author emphasizes 
that the successful transfer of equipment or 
technology does not guarantee the joint venture 
success. It is also mentioned that firms from 
developed countries establish ventures with local 
partners as a way to disseminate their technology 
to as many markets as possible. 
 To bring complementary product line to the 
venture: It could be potential future contribution 
of either partner. It was not examined however 
by any of the studies mentioned. Stopford and 
Wells mention it as a suggestion from the 
executive interviewed. The work of Kogut and 
Anand (2002) suggests it as an important 
contribution from the foreign partner. 
 
5.0  DATA COLLECTION 
 
Data examined in this study were collected using 
questionnaires filled in during executive face to face 
semi-structured interviews in 2008. Twenty–three 
firms associated with biotechnology were included 
as a result of the national scope of this association 
(Biotech Corp, 2008). It represents approximately 20 
percent of the estimated 120 firms operating in the 
biotechnology area in Malaysia (MABIC, 2008). 
Malaysian Biotechnology Corporation was, at the 
time of the survey, the only national association of 
biotechnology firms, and approximately 80 percent 
of associated firms were surveyed. A total of 19 
managing directors (MDs) (connected with 18 firms) 
were interviewed. The firms were located in Kuala 
Lumpur, and several cities in the State of Penang. 
 
In parallel, a ‘panel’ of 15 specialists, or researchers 
connected to governmental agencies and university 
research centres, was used to classify the firms 
according to their suitability for international joint 
ventures² (Dacin et al, 2002). 
 
Future potential contributions from both partners 
(local and foreign) were listed, and a Likert scale 
from ‘0’ (minimum importance) to ‘5’ (maximum 
importance) was allocated to each contribution. As 
the Malaysian environment has proved itself very 
unpredictable, the specialists were also used as a 
control group for any circumstantial bias that could 
occur on the assessment of the MDs. This check was 
necessary because the executives interviewed were 
part of the same association (Biotech Corporation) 
and their views could be influenced by their 
associates. In this case, the control group, that is the 
specialists, did not have any connection with Biotech 
Corporation. 
 
6.0  RESULTS 
6.1  Grouping of Firms 
 
The ‘panel’ of 15 specialists evaluated the 18 firms 
whose MDs were interviewed. It can be observed 
that the curve presents three distinct regions: a steep 
slope comprising six firms with higher grades, a 
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nearly flat part in the middle showing six firms with 
grades around 2.5, and a less accentuates slope for 
the six firms presenting the lowest grades. The six 
firms of the upper third were defined as the most 
suitable group, and the remaining firms as the group 
least suitable to establish a strategy of joint ventures 
with foreign firms (firms not yet operating in 
Malaysia). As a measure of the separation of the 
proposed groups, the distance between the average 
of grades within each group and the extreme grades 
is 50 percent. 
 
6.2 Views of Potential Contributions from 
the Local Partner 
 
MDs and specialists involved with biotechnology 
were asked to grade the importance of 18 potential 
contributions from a typical Malaysian partner firm 
to hypothetical strategic alliances with a foreign 
firm. The values allocated to each contribution, 
obtained from the questionnaires are shown in Table 
1, five sub-groups of answer were considered in the 
analysis: the MDs as a whole, the MDs from the 
most suitable and from the least suitable firms, the 
specialists, and the combined answer of MDs and 
specialists. 
 
Table 1: Importance of the Local Partner Contributions 
Contributions All Spec. MD  MS LS 
Capital 1.68 1.74 1.60 1.33 2.00 
Raw materials 2.79 2.68 2.93 2.00 2.83 
General knowledge 4.09 3.95 4.27 3.83 4.08 
Local financing 3.35 3.11 3.67 3.00 3.25 
Local personalities 3.29 3.47 3.07 3.67 3.42 
Political interventions 2.27 2.47 2.00 2.33 2.75 
Political advantages 2.62 2.47 2.80 2.83 2.42 
Governmental requirements 2.94 3.00 2.87 2.83 3.25 
Speed of entry into local market 3.65 3.53 3.80 3.67 3.50 
Acc. to loc. market vs. subsidiary 3.59 3.53 3.67 3.67 3.42 
Loc. market for partner’s prod 3.35 3.42 3.27 3.00 3.58 
Export opportunities 2.29 2.37 2.20 2.33 2.58 
Managing director 2.91 3.05 2.73 2.33 3.25 
Marketing director 3.18 3.37 2.93 3.50 3.25 
Technical personnel 2.68 2.74 2.60 2.50 2.83 
Low cost labour 2.44 2.84 1.93 3.83 2.50 
Technology  1.44 1.53 1.33 0.50 2.17 
Supplementary products 2.47 2.63 2.27 2.00 3.00 
Spec. = specialist; MD = managing director; MS = most suitable;  
LS = least suitable 
 
First, the subgroups as sets of ranked contributions 
were compared. The spearman coefficient between 
the sub-group of MDs and the subgroup of 
specialists is high (0.88, significance 0.03 percent) 
indicating a high conformity between the ranking of 
these two groups of respondents. Consequently, the 
analysis can proceed by using the combination of the 
answers or the ‘all’ subgroup. This result indicates 
the absence of any bias in the perception of MDs 
when compared to specialists. 
 
As for the comparison between the answers from 
MDs of the most suitable firms and those of the least 
suitable firms, the statistical analysis suggests a 
difference in views (Spearman’s 0.64, Mann-
Whitney test to rank 2 percent). This shows the need 
for a more careful analysis in order to determine the 
specific differences in positions of the potential 
contributions (see table 1). The relative ranks of 
potential future contributions from the local partner 
are shown in Table 2. The relative ranks for standard 
deviations are shown in table 3. 
 
 
Table 2: relative rank of the Potential contributions from 
the 
Local Partner (1= Highest importance; 18= Lowest 
Importance) 
 
Contributions All Spec. MD MS LS 
Capital 17 17 17 17 18 
Raw materials 10 8 12 16 11 
General knowledge 1 1 1 2 1 
Local financing 4 3 7 7 6 
Local personalities 6 6 4 4 5 
Political interventions 16 15 14 12 13 
Political advantages 12 9 15 10 15 
Governmental requirements 8 11 8 8 7 
Speed of entry into local market 2 2 3 3 3 
Acc. to loc. market vs. subsidiary 3 4 2 5 4 
Loc. market for partner’s prod 5 5 5 9 2 
Export opportunities 15 13 16 13 14 
Managing director 9 10 9 14 8 
Marketing director 7 7 6 6 9 
Technical personnel 11 12 10 11 12 
Low cost labour 14 16 11 1 16 
Technology  18 18 18 18 17 
Supplementary products 13 14 13 15 10 
Spec. = specialist; MD = managing director; MS = most suitable;  
LS = least suitable 
 
Table 3: Relative Ranks of the Standard Deviation of the 
Local 
Partner Potential contributions (1–18 =Highest-Lowest) 
Contributions All Spec. MD MS LS 
Capital 12 10 13 12 10 
Raw materials 2 3 2 3 2 
General knowledge 18 12 18 17 18 
Local financing 10 16 10 13 7 
Local personalities 15 6 17 14 17 
Political interventions 5 4 6 9 8 
Political advantages 4 1 12 16 6 
Governmental requirements 9 9 11 7 11 
Speed of entry into local market 17 13 16 16 12 
Acc. to loc. market vs. subsidiary 13 11 14 6 13 
Loc. market for partner’s prod 11 14 8 5 14 
Export opportunities 3 7 3 1 3 
Managing director 6 8 4 8 5 
Marketing director 7 15 5 11 4 
Technical personnel 8 2 15 10 16 
Low cost labour 1 5 1 4 1 
Technology  16 18 9 18 9 
Supplementary products 14 17 7 2 15 
Spec. = specialist; MD = managing director; MS = most suitable;  
LS = least suitable 
 
Although the most important local partner potential 
contributions, such as ‘general knowledge’ and 
‘faster entry and access to market’ are predicted in 
the literature, ‘political intervention’ was place at a 
very low position (16th out of 18), contrary to 
existing literature on developing countries. The 
importance of the items ‘Faster entry into the local 
market’ considering other existing alternatives to the 
foreign partner’ (as licensing, exporting, or wholly 
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owned subsidiaries), and ‘access to local markets vs. 
subsidiary’ shows the importance of the market for 
the foreign investor. The latter results were also 
predicted in the literature, and reflect the potential of 
the Malaysian market. 
 
However, when comparing the group of most 
suitable (MS) firms with the least suitable (LS) more 
interesting results arise. The MS firms place ‘low 
cost labour’ as a contribution of the local partner in 
the first rank of importance. Dong et al. (1997) 
recently pointed out this as an important contribution 
of the local partner in their study in China. Contrary 
to that study however, Malaysian MDs were 
comparing the salaries of highly qualified personnel 
in the biotechnology area in Malaysia with those 
salaries offered internationally or in developed 
countries. In contrast, the LS place it as on of the 
least important items, indirectly by implication 
confirming its importance in a successful venture. 
 
Other local partner contributions seen differently 
were ‘local market for foreign partner prod/s’, MDs, 
‘Raw materials’, ’supplementary products’, all 
ranked as lower importance by the MS firms, and 
‘political advantages’ ranked higher by the MS 
firms. The most controversial items (items 
presenting the highest standards deviations) were 






6.3  Views on the Potential Contributions 
from the Foreign Partner 
 
MDs and specialists were also questioned on the 
importance of potential contributions from a typical 
foreign firm (a firm not yet operating in Malaysia) to 
establish a hypothetical joint venture with a typical 
Malaysian firm. The questionnaire listed 11 potential 
contributions found in the literature. The results are 
shown in Table 4. As previously, five subgroups of 
answers were considered in the analysis: the MDs as 
a whole, the MDs from the most suitable and from 
the least suitable firms, the Specialist, and the 
combined answer of MDs and specialists. 
 
The subgroups as sets of ranked potential 
contributions were compared. In a similar way to 
local contributions, the correlation coefficient 
between the subgroups of Specialist and the MDs 
(corr=0.91;sign=0.3 percent) is high suggesting 
similar views by these groups of respondents, and 
the consequent absence of bias on the part of the 
MDs. 
 
The correlation coefficient between ‘most suitable’ 
and ‘least suitable’ firms is higher (0.93 at 0.3 per 
cent sign) than the contributions of the local 
partners. This suggests a more homogeneous view of 
the importance of foreign partner contributions when 
compared to the previous results for the local partner 
contributions (see Table 4). The relative ranks of 
potential future contributions from the foreign 
partner are shown in Table 5. The relative ranks for 
the standard deviations are shown in table 6. 
 
Table 4: Importance of the Foreign Partner 
Contributions 
Contributions All Spec. MD MS LS 
Capital 3.71 4.07 3.42 3.00 3.58 
Raw materials 2.44 2.07 2.74 2.50 3.08 
Gen. knowledge of foreign c’try 2.41 2.13 2.63 3.33 2.25 
Political adv. from foreign c’try 2.21 2.13 2.26 2.33 2.42 
Easier exports (JV products) 3.68 3.67 3.68 3.50 3.75 
Easier exports (local partner) 3.41 3.33 3.47 3.50 3.67 
Managing director 1.50 1.20 1.74 2.00 1.75 
Marketing director 1.77 1.40 2.05 1.83 2.08 
Technical personnel 3.88 3.73 4.00 4.00 4.00 
Technology 4.65 4.60 4.68 4.83 4.58 
Supplementary products 4.29 4.33 4.26 4.00 4.42 
Spec. = specialist; MD = managing director; MS = most suitable;  









Table 5: Relative rank of the Potential 
Contributions  
from the foreign Partner (1–18 =Highest-Lowest 
Deviation) 
Contributions All Spec. MD MS LS 
Capital 4 3 6 7 6 
Raw materials 7 9 7 8 7 
Gen. knowledge of foreign c’try 8 7 8 6 9 
Political adv. from foreign c’try 9 8 9 9 8 
Easier exports (JV products) 5 5 4 4 4 
Easier exports (local partner) 6 6 5 5 5 
Managing director 11 11 11 10 11 
Marketing director 10 10 10 11 10 
Technical personnel 3 4 3 2 3 
Technology  1 1 1 1 1 
Supplementary products 2 2 2 3 2 
Spec. = specialist; MD = managing director; MS = most suitable;  
LS = least suitable 
 
As is to be expected, the contribution of the foreign 
partner seen as most important is technology. This 
conclusion is strongly confirmed by the equally 
highly-ranked contributions ‘to bring supplementary 
product lines to the joint venture’ and ‘to bring 
managers or experts in productions, R& D or other 
technical area’ (know-how). The next item in 
importance was ‘access to foreign market for goods 
produced by the joint venture’. Cleary, technology is 
seen as essential to the present stage of development 
of the commercial biotechnology industry in 
Malaysia. Access to foreign markets is placed in the 
second position if importance. Although MDs agree 
strongly within their group, their Specialists place 
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‘capital’ at a much higher rank of importance. The 
apparent financial crisis in the country at the time of 
the survey does not seem to influence the 
perceptions of executives. 
 
One difference in perceived importance between the 
MS and the LS is ’general knowledge of a foreign 
country’ the MS executives placing it as of higher 
importance.  
 
With regard to the standard deviation, the more 
controversial item was ‘raw materials’, ‘general 
knowledge of a foreign country’ presented the 
highest standard deviation of the subgroup of  least 
suitable firms, differing from the most suitable 
group of firms for which it was placed in a medium 
position. 
 
Table 6: Relative ranks of the SD of the Foreign 
Partner Potential Contributions (1–18 =Highest-
Lowest Deviation) 
Contributions All Spec. MD MS LS 
Capital 3 5 3 2 4 
Raw materials 1 3 1 1 2 
Gen. knowledge of foreign c’try 2 1 2 7 1 
Political adv. from foreign c’try 4 2 4 6 3 
Easier exports (JV products) 7 6 7 5 7 
Easier exports (local partner) 8 7 8 8 8 
Managing director 5 4 5 3 6 
Marketing director 6 10 6 4 5 
Technical personnel 9 8 9 9 9 
Technology 10 9 11 11 10 
Supplementary products 11 11 10 10 11 
Spec. = specialist; MD = managing director; MS = most suitable;  
LS = least suitable 
 
7.0  CONCLUSION 
 
This paper points out the importance, according to 
the views of Malaysian MDs and Specialists 
connected to the biotechnology area, of expected 
future contributions from the partners in a joint 
venture with one or more European (or US) foreign 
firms, i.e firms not yet operating in Malaysia. 
 
The comparison of the views of MDs from the most 
suitable firms and from the least suitable firms has 
indicated differences regarding the local partner 
potential contributions. One of the most 
controversial items, which also presented a 
substantial contrast in ranking between these two 
groups of firms ranked this contribution as the most 
important. As most of the MDs were comparing the 
salaries of highly qualified personnel, and 
biotechnology is not labour intensive, it seems 
reasonable to assume that those salaries are 
perceived to be considerably lower in Malaysia (or 
for this matter in emerging economies) than those in 
developed countries. This contribution has not 
previously been identified in the literature 
concerning high-technology sectors. There are 
differences in perceptions also with regard to ‘raw 
materials’, ‘political advantages’, and MDs’. 
 
The most relevant potential contribution from the 
local partner as pointed out by both MDs and 
specialists was ‘general knowledge of the local 
economy, politics, and customs’. The item ‘fastest 
speed of entry into the local market, considering the 
existing alternatives to the foreign partner’ has also 
been pointed out as important. It endorses the 
literature. Moreover, Glaister and Buckley (1997) 
and Hitt et al. (2004; 2000) in studying partner 
selection criteria within developed country firms, 
also indicated similar criteria affecting partner 
selection3. The result is in line with the literature 
which considers US multinational managers in the 
beginning of the 70s (Stopford and Wells, 1972). 
This observation, and related ideas4, implies that the 
line of thought of Malaysian executives in the year 
2008 agree with those of US MNE executives of the 
70s. It could indicate paths for future research.  
 
As to foreign partner potential contributions, the 
most prominent item was ‘technology’, followed by 
‘complementary line of products’ and ‘technical 
personnel’, re-emphasizing the importance of the 
item technology. Contractor and Lorange (1988, 
p.13) and Holtbrugge (2004) point out the 
importance of co-operative agreements in 
technological joint developments, particularly of 
biotechnology firms, whereas Hladik (1988, pp. 189-
190), Hoskisson et al. (2000) and Sim (2006) 
suggest its importance to firms in LDCs (or in 
emerging economies) in accessing technology. 
 
On the development of strategies of international 
strategic alliances, the expectations listed and 
examined in this paper may be of fundamental 
importance because they bring out important 
elements of negotiation. It is hoped that this initial 
study of potential future contributions of the partners 
of an international strategic alliances with an 
emerging market firm can encourage this type of 
enterprise in the area of biotechnology. The joint 
venture could become an important channel for 
emerging economies to obtain biotechnology. 
 
1. Traditional biotechnology with intermediary 
techniques utilizes advances knowledge of 
genetics and biology (but no genetic 
manipulation). 
2. Specialists are professionals connected to 
biotechnology but not to firms interviewed, were 
asked to allocate, according to their perception, 
scores to the capability of each firms in regards 
the potential contributions to a foreign partner 
firms. These scores weighted by the importance 
assigned to each contribution resulted in a grade 
to each firm.  
3. Glaister and Buckley (1997) point out, as some 
of the most important partner selection criteria, 
the knowledge of the local market and of local 
culture which are connected to ‘general 
knowledge of the local economy, politics, and 
customs’, as well as links with buyers and 
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distribution channels which would lead (and thus 
are taken as associated) to a ’faster entry into the 
local market’. 
4. Sim et al. (2006) pointed out a gap of 
approximately four decades while considering 
the size of large Malaysian and US companies 
(Malaysian largest companies in 2008 would 
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